• VAPOUR - A Randomized-Controlled Study of Vertebroplasty for Acute Painful Osteoporotic Fractures

    • Nov 30, 2016
    • Justin Slavin, MD

    • Spine

    Two prior RCTs showed no benefit for vertebroplasty compared to non-surgical management of osteoporotic fractures up to 12 months after onset. The VAPOUR study is a randomized, placebo-controlled, double-blinded trial to assess effectiveness of vertebroplasty for acute fractures. 120 patients with osteoporotic fractures causing back pain rated at least 7/10 for less than six weeks in duration were randomized into either vertebroplasty (N=61) or placebo surgery (N=59) groups and followed for 6 months. The primary outcome measure was the NRS pain score <4/10 at 14 days: 44% of the vertebroplasty group had pain scores <4/10 compared to 21% in placebo group (p=0.011). Mean reduction in NRS pain score was also greater for vertebroplasty than for control patients. Analgesic consumption was reduced in the vertebroplasty group after 3 months and inpatient hospital stay was reduced by 5.5 days. Subgroup analyses showed particular benefit for those with thoracolumbar junction fractures (p=0.0012). In summary, vertebroplasty is effective at reducing pain for acute painful osteoporotic fractures in this RCT.

    Source

    National Center for Biotechnology Information

We use cookies to improve the performance of our site, to analyze the traffic to our site, and to personalize your experience of the site. You can control cookies through your browser settings. Please find more information on the cookies used on our site here. Privacy Policy